
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
- About
Direxion Daily LLY Bull 2X Shares (ELIL)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: ELIL (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $0
1 Year Target Price $0
0 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 15.91 - 26.62 | Updated Date 04/5/2025 |
52 Weeks Range 15.91 - 26.62 | Updated Date 04/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Direxion Daily LLY Bull 2X Shares
Company Overview
History and Background
The Direxion Daily LLY Bull 2X Shares (LLYU) is an exchange-traded fund (ETF) that seeks daily investment results, before fees and expenses, of 200% of the daily performance of the common stock of Eli Lilly and Company (LLY). It was created and is managed by Direxion.
Core Business Areas
- Leveraged ETF: LLYU is a leveraged ETF, meaning it uses financial derivatives and debt to amplify the returns of its underlying index, which is the daily performance of Eli Lilly (LLY) stock. It is not intended for long-term investment.
Leadership and Structure
Direxion is the investment advisor for LLYU. The fund's performance is directly tied to the management strategies and decisions of Direxion. The organizational structure involves portfolio managers and analysts who track LLY and manage the fund's assets.
Top Products and Market Share
Key Offerings
- Direxion Daily LLY Bull 2X Shares (LLYU): This ETF aims to deliver twice the daily return of Eli Lilly (LLY). Market share is not directly applicable to leveraged ETFs as it depends on trading volume and assets under management (AUM). Competitors are other leveraged and inverse ETFs focused on the pharmaceutical or healthcare sectors. Actual market share numbers are not publicly available.
Market Dynamics
Industry Overview
The ETF industry is highly competitive, with numerous providers offering various investment strategies. Leveraged ETFs cater to sophisticated investors seeking short-term gains.
Positioning
LLYU is positioned as a short-term trading tool for investors who are bullish on Eli Lilly (LLY). It's a niche product within the broader ETF market.
Total Addressable Market (TAM)
The TAM for leveraged ETFs is a fraction of the total ETF market. LLYU's position is tied to the trading interest in LLY and the demand for leveraged exposure. Estimating a precise TAM is difficult due to its dependence on trading activity.
Upturn SWOT Analysis
Strengths
- Potential for high daily returns (2x LLY)
- Provides leveraged exposure without margin account
- Liquid and easily tradable
Weaknesses
- High risk due to leverage
- Erosion of value due to compounding (volatility drag)
- Not suitable for long-term investment
- High expense ratio
Opportunities
- Increased investor interest in LLY
- Short-term market rallies in LLY
- Expansion of Direxion's ETF offerings
Threats
- Decreasing investor interest in LLY
- Regulatory changes affecting leveraged ETFs
- Increased competition from similar products
- Significant market downturn in LLY
Competitors and Market Share
Key Competitors
- None
Competitive Landscape
LLYU's advantage lies in providing leveraged exposure to LLY specifically. Its disadvantage is the inherent risk of leveraged ETFs and the potential for volatility drag.
Growth Trajectory and Initiatives
Historical Growth: Growth is tied to LLY's stock performance and investor demand for leveraged exposure.
Future Projections: Future performance depends on the outlook for LLY and the overall market sentiment towards leveraged ETFs.
Recent Initiatives: Direxion may launch similar ETFs tracking other companies or sectors, but specific initiatives related to LLYU are unlikely.
Summary
LLYU is a high-risk, high-reward ETF designed for short-term trading of Eli Lilly's stock. It offers leveraged exposure but suffers from volatility drag, making it unsuitable for long-term investment. Its performance hinges on LLY's daily price movements, and investors should be aware of the inherent risks before investing. Direxion offers a specific product and it performance is based on the success of Eli Lilly shares. This creates a very cyclical market position.
Peer Comparison
Sources and Disclaimers
Data Sources:
- DirexionShares.com
- ETF.com
- Yahoo Finance
Disclaimers:
Leveraged ETFs are not suitable for all investors. Past performance is not indicative of future results. Consult with a financial advisor before investing.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Direxion Daily LLY Bull 2X Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2025-03-26 | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund, under normal circumstances, invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of LLY and financial instruments, such as swap agreements and options, that, in combination, provide 2X daily leveraged exposure to LLY, consistent with the fund"s investment objective. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.